# Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

> **NCT01545349** · PHASE1 · COMPLETED · sponsor: **Patricia L. Hibberd** · enrollment: 30 (actual)

## Conditions studied

- Healthy
- Influenza

## Interventions

- **BIOLOGICAL:** Lactobacillus rhamnosus GG ATCC 53103 (LGG)
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Live attenuated influenza vaccine

## Key facts

- **NCT ID:** NCT01545349
- **Lead sponsor:** Patricia L. Hibberd
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01545349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01545349, "Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01545349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*